Home/Filings/4/0001062993-23-000800
4//SEC Filing

MELLETT PAUL J 4

Accession 0001062993-23-000800

CIK 0001177648other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 7:11 PM ET

Size

6.5 KB

Accession

0001062993-23-000800

Insider Transaction Report

Form 4
Period: 2023-01-09
MELLETT PAUL J
Treasurer and CFO
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-092,8120 total
    Exercise: $14.18Exp: 2023-01-17Common Stock (2,812 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-09$14.18/sh+2,812$39,87488,463 total
Footnotes (1)
  • [F1]100% of the shares subject to the option are fully vested and exercisable.

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeother

Related Parties

1
  • filerCIK 0001185034

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 7:11 PM ET
Size
6.5 KB